Management Trainee

Programme

Agenda

• What we do…

– About Ranbaxy Group

• How we do it…

– Ranbaxy Advantage

• How you fit in...

– The Management Trainee Program

What we do……

An Overview

• Among India’s largest pharmaceutical companies

• Ranbaxy & Daiichi Sankyo combined rank among the top 20 global pharmaceutical

companies

• Worldwide Presence

• Ground presence in 46 countries, products sold in over 125 countries

• Manufacturing locations in 7 countries

• Global consolidated sales – US $ 1519 Mn (2009)

• Highest R&D spender amongst Indian Pharmaceutical companies

• Business

- International 77%

- Domestic 23%

• Around 14000 employees globally represented by 50 nationalities

Where we operate

Ranbaxy – Daiichi Sankyo Partnership

• Significant and sustained operational and strategic synergies

across the globe

– Collaborative marketing opportunities leveraging

Ranbaxy’s substantial footprint

– Manufacturing

– R&D

– Global supply chain

– IT functions

• Combining innovator and generics capabilities, to straddle full

spectrum of pharma value chain

Hybrid

Business

Model

Global Pharma Innovator Global Generics Company

• A path breaking confluence that redefines the global pharma paradigm

• Strategic combination creates an Innovator and Generic Pharmaceutical Powerhouse

Ranbaxy Corporate Office

Our state-of-the-art Head Quarters is located at Gurgaon, New Delhi NCR

The ‘Brain Center’ for all our Global Strategies

Vision, Mission & ValuesMission

• To become a Research-based International Pharmaceutical Company”

Vision 2012

• Achieve significant business in proprietary prescription products by 2012 with a strong presence in developed markets

Values

• Achieving customer satisfaction is fundamental to our business

• Provide products and services of the highest quality

• Practice dignity and equity in relationships and provide opportunities for our people to

realise their full potential

• Ensure profitable growth and enhance wealth of the shareholders

• Foster mutually beneficial relations with all our business partners

• Manage our operations with high concern for safety and environment

• Be a responsible corporate citizen

• Dedicated Facilities for Innovative & Generics Research

• More than 1200 R&D Personnel

• Highest R&D spender amongst Indian Pharmaceutical companies

• NDDS based products (4 platform technologies)

• NDDR - Arterolane + PQP (Anti malaria)

• One program with GSK (Respiratory)

• R&D collaborations with Industry & Academia

Collaboration in Clinical Development of NCE

Research & Development

Research & Development

State-of-the-art R&D facilities based in Gurgaon (India)

R&D I R&D IIIR&D II

R&D IV R&D V R&D VI

Global Manufacturing Strengths

• cGMP compliant world-class API & Dosage Forms manufacturing

facilities across the globe

• 7 manufacturing locations worldwide

• API facilities - increasing vertical integration

• Creating capacities for specialty products

• New facilities added in cost advantageous geographies

Global Manufacturing Strengths

India

USA Ireland NigeriaRomania

South Africa Malaysia

Key Strengths

• Our

innovative

use of

technology

• Confidence

in our

expertise

• Empowerment

&

Independency

• Calculated

risk taking

ability

• The aptitude

of our people

• Our ability

to react

swiftly

• Knowledge

of our

markets

Ranbaxy is the partner of choice

Global Sales Split

* CIS includes Russia & Ukraine belt

US $ 1519 Mn (2009)

All figures in US $

269 Mn 18%

397 Mn 26%

86 Mn6% 441 Mn

29%

214 Mn 14%

112 Mn7%

CIS*

Asia

RoW

APIEurope

North

America

How we do it ...

Global Pharmaceutical Landscape

Global Pharmaceuticals Market:

• 2009: ~ US $ 727 Bn (+5.7%)

Global Generics Market:

• 2009: US $ 83 Bn (+7.7%)

Key Drivers of Generics:

Significant patent expiries (~US

$ 80 Bn drugs) through 2012

• Increasing generic penetration

• Rationalizing healthcare costs

• Emerging markets opportunity

Source : IMS Mat Nov 2009

Global Pharma Market Slice

US $ Bn

316

226

152

80 33

North America Europe

Africa, Asia and Australia Japan

Latin America

Advantage India

India will be the 10th largest pharma market by 2015 with drivers like:

• Epidemic of ‘Lifestyle’ illnesses

• Medical Infrastructure, Affordability & Healthcare Reach

• India is the Global Pharma Outsourcing Hub

• Enhanced clinical research capabilities

• Large talent pool

• Treatment Naïve patients

• High quality standards for trials

• Strong manufacturing backgrounds

• Largest # of US FDA approved plants outside the US 61 plants

• Large pool of API & Finished Dose formulation

• manufacturing facilities

• India is 3rd largest API manufacturer with USD 2 Bn

• 40% of US DMF filings from India

• Low cost & high quality of manufacturing

Source: IMS Health: MIDAS, MAT Dec 2006 & IMS World Review; Analyst projections;

McKinsey India Pharmaceutical Demand Model, India – Includes institutional sales

GROWTH IN THE DOMESTIC MARKET & STRONG INDUSTRY FUNDAMENTALS

The Global Generics Advantages

Consolidation

Growth Potential

• Size & Scale

• Therapeutic Width

• Operational Synergies

• Pressure on Vanilla Gx

• Move to Specialty/ Niche

Product Portfolio

• Patent Expiries

• New Markets

• Healthcare Costs

India Factor

• Scientific Talent

• Cost Advantage

• Gx / Rx

• Competencies

Ranbaxy Business Model

Global Reach Product

Portfolio

Research &

DevelopmentManufacturing

Developed Markets

North America, EU,

Japan, Australia

Emerging markets

India Romania, CIS

South Africa, Brazil

Mexico

• Generics,

• Branded Generics

• OTC

• Generics/NDDS*

• Complex/Niche/FTF*

• Select New Chemical

Entities

• Dosage Form

• API * - Vertical Integration

• In-house/Outsource

* NDDS – Novel Drug Delivery System, API – Active Pharmaceutical Ingredients, FTF – First to File

Competitive Advantage @ Ranbaxy

Competetive cost, innovative and high quality product flow

Manufacturing

Efficiencies

Aggressive

Marketing

R&D

Capabilities

Highly competitive

domestic market

Labor

Infrastructure

Global Quality Standards

Skilled Scientist Pool

- Generics

- Innovative Research

Process Chemistry

Expertise

Global Head Quarter INDIA

o Among India’s largest pharmaceutical companies

o One of the largest distribution networks that comprises over 4000

field force

o Dedicated task forces for specialized & chronic therapies

o 18 brands in Top 300 of Industry

o Project ‘Viraat’ – A key initiative to strengthen company’s

domestic leadership position

Developed Market Presence

• Largest generic market worldwide

• Significant patent expiries through 2012

• Mature generic market

• Ranbaxy is the fastest growing generics company in Canada

USA

Canada

EU

Japan

• Germany, UK - mature markets

• France, Spain, Italy, Romania - emerging markets

• Ranbaxy has presence in 23 of the 27 EU countries

• Emerging generic market, < 5% generic penetration

• 1st Indian pharma company

Emerging Markets Presence

• Among India’s largest pharmaceutical companies

• Growing at a fast pace

• Ranked as the No. 1 Generics Company

• Strategic for servicing EU operations

• Strong base in acute therapies

• Fast expanding into chronic and OTC segments

• Key market in the African continent

• A strong No. 5 player in the region

India

Romania

Russia &

Ukraine

South Africa

To capitalize on the opportunities in the ongoing consolidation for…

... providing a strategic and value accretive fit

Inorganic Strategy

• Size and scale in developed & emerging markets

• Expansion of geographical reach

• Access to niche and complex products / therapeutic areas

• Costs efficiencies in manufacturing and R&D

Key Acquisitions & Alliances

INDIA

* Zenotech

* Cardinal Drugs

* Ochoa Labs

* Biovel

OTHER COUNTRIES

* Terapia (Romania)

* Be-Tabs(South Africa)

* Allen (Italy)

* Mundogen (Spain)

More than US $ 500 Mn spend on M&A

$

Corporate Social Responsibility

Ranbaxy Community Healthcare Services founded in 1979

Covering areas of :

* Maternal Child Health

* Family Planning

* Reproductive Health

* Adolescent Health

* Health Education

* AIDS awareness

* Preventive

* Promotive

* Curative Services

It has an integrated approach

Corporate Social Responsibility

• Corporate Social Responsibility is inscribed in our VALUES

• Ranbaxy Rural Development Trust set up in 1978 (later re-christened

as ‘Ranbaxy Community Health Care Society’)

• We serve about 2 lakh people staying in 110 villages and urban slum

areas; of Punjab, Haryana, Himachal Pradesh, Madhya Pradesh

• Launched Mobile Healthcare services : infrastructure includes 14

Mobile Health Care Vans

• Public Private Partnership (PPP) with the Punjab State Government, to

deliver healthcare services in identified districts of Punjab. The program

- Ranbaxy Sanjeevan Swasthya Seva - is being rolled out in a phased

manner

• Partnered with State & Central Government of India in critical areas

HIV/AIDS, tuberculosis, Malaria, Polio, non-communicable chronic

diseases and female foeticide.

Management Trainee Programme

Multifaceted Interaction

Corporate HR

Conducts/ facilitates

Management Trainee

programme. Acts as

sounding board

Cross Functional Team &

Steering Committee

(All Mentors)

Coach Trainees, removes

Roadblocks, conducts

assessments,

Finalizes placements and set

Direction for the program.

Business/Functional

Head

Acts as guide –

Agrees projects with

his/her team & is

responsible for

direction, support &

assessment

Management

Trainees –

Accountable for

learning & delivery

MTP @ Ranbaxy

Purpose

The purpose of theprogramme is to helpthe MT to experiencethe various facets ofRanbaxy and therebyprepare for theassigned role

Process

The programme focuses predominantly onexperiential learning through on the jobprogrammes. This is achieved through

Basic understanding of the business throughlectures and interactive sessions

Project work in various areas of the keyfunction, across different locations

Self-awareness sessions Self development with training on key

behavioral attributes

The Programme

Total Duration of MT: 12 months with 3 Rotations

First 15 days

InductionInduction provided by Corporate HR

Project Assignment 1Project provided by respective assigned department

Project Assignment 2 & 3Project suggested by respective department but in different locations

Next 3 and a

half months

Last 8 months

Informal Review of Progress

Review of Progress by Coach/Manager

Review of Progress at the end of 12 months

Objective:-Induction helps MT to

know about Ranbaxy as an organization, its culture, values, ethics and company vision & mission

Objective:-Provide platform for

the MT to get familiarized with the functioning of assigned area of interest & accelerate learning curve

Objective:-Provide an in-depth

understanding of the function at different locations

First 18 months

Suggested Career Ladder - Illustrative

International Assignment

Cross Functional Exposure

Continuous Development Opportunity

Competitive Pay Packages

Diversity

A B C DD

Job Class Progression

E

Some of Our Graduate Top Achievers...

NameCurrent

DesignationFunction Area Batch Institute Name

Neeraj KukretiDirector - Business

Solutions

Business Solutions

Group1995 FMS

Sandeep Juneja Director - M&ACorporate

Development1994 IIFT

Anupam Bhatt Director - HRPharma

Manufacturing1990 XISS

K. Venkatachalam Sr. VP & RD Ranbaxy Inc. (USA) 1993 SPJ

Abhimanyu OjhaGM-Global Hybrid

Business

Global Hybrid

Business2002 IMI

Hemant DhondgeGM-Production

PlanningGlobal Supply Chain 1993

Sydenham Institute of

Bombay University

Karan KhambatiProduct Manger -

UkraineCIS 2006 NMIMS

Poonam Bharti GM-HR R&D 1995 TISS

Ravi Natarajan GM-MaterialsGlobal Material

Sourcing1990

Symbiosis Institute –

Poona University

Selection Process

Recruitment through campus selection process in business

Schools

CVs short listed as per the predefined parameters

Group Discussion

Personal Interview

Psychometric Test for short listed candidates

What we offer

• Earning Potential (CTC) up to Rs. 9,58,660 annual

• Performance driven career growth

• Growth through Continuous Learning

• Opportunity of working with a Global Pharma Major in the fast paced Pharma market

• One Time Relocation Expenses: Rs. 25,000/-

• Fixed Total

• Includes Stipend, Subsidies – House

Rent, Conveyance, Education, Utility, Medical, Leave Travel, Bonus, Telephone, Hard

Furnishing, Retirals

• Variable pay

• Other Benefits

• Group Hospital Insurance around Rs. 1.20 lac per annum for per declared dependent

(immediate family)

• Group Term Insurance – Varies (based on eventuality) – up to maximum of Rs. 9.50 lac

Salary

Details

Questions

Step 1: Read more about the organisation from official website www.ranbaxy.com

Step 2: All the candidates have to go through the entire selection process and final selection

will be the sole discretion of the organisation.

Step 3: Dates for campus recruitment will be communicated to the Placement Coordinator

Step 4: For any query please route through your respective Placement Coordinator

Step 5: Offer will be treated final only after receiving written confirmation from the

organization

Step 6: The offer of appointment is subject to your successful completion of company’s

medical examination and verification of your testimonials/certificates

Step 7: One year training will start from June 1, 2011

Step 8: For any clarification related to MT Programme, Training, joining and other related

matters please contact at MTP@ranbaxy.com

Next Steps

Disclaimer

• This presentation includes forward-looking statements. Such statements are only

predictions and actual events or results may differ materially. For a discussion of

important factors which could cause actual results to differ from the forward-looking

statements, please refer to Ranbaxy Laboratories Limited Annual Report and

Accounts

• Nothing in this presentation constitutes or shall be taken to constitute an offer,

invitation or inducement to any person to invest in Ranbaxy and no reliance should

be placed on the information contained in it in connection with any investment

decision or for any other reason. Ranbaxy Laboratories Limited and its affiliates do

not make any representation or warranty, express or implied, with respect to the

completeness, adequacy or accuracy of the information contained in this

presentation

THANK YOU